Moving Lassa Fever Research and Care Into the 21st Century

Affiliations

Comment

William A Fischer 2nd et al. J Infect Dis. 2017.

. 2017 Jun 15;215(12):1779-1781.

doi: 10.1093/infdis/jix206.

No abstract available

Comment on

A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses.
McElroy AK, Akondy RS, Harmon JR, Ellebedy AH, Cannon D, Klena JD, Sidney J, Sette A, Mehta AK, Kraft CS, Lyon MG, Varkey JB, Ribner BS, Nichol ST, Spiropoulou CF. McElroy AK, et al. J Infect Dis. 2017 Jun 15;215(12):1862-1872. doi: 10.1093/infdis/jix201. J Infect Dis. 2017. PMID: 28863472 Free PMC article.

1. Kerber R, Reindl S, Romanowski V et al. . Research efforts to control highly pathogenic arenaviruses: a summary of the progress and gaps. J Clin Virol 2015; 64:120–7. - PubMed
1. Khan SH, Goba A, Chu M et al. ; Mano River Union Lassa Fever Network New opportunities for field research on the pathogenesis and treatment of Lassa fever. Antiviral Res 2008; 78:103–15. - PubMed
1. Oestereich L, Lüdtke A, Ruibal P et al. . Chimeric mice with competent hematopoietic immunity reproduce key features of severe Lassa fever. PLoS Pathog 2016; 12:e1005656. - PMC - PubMed
1. World Health Organization. Epidemic focus: Lassa fever. Wkly Epidemiol Rec2016. http://www.who.int/wer/2016/wer9121.pdf?ua=1. Accessed 18 January 2017.
1. World Health Organization. WHO calls for early diagnostic tests for Lassa fever 2016. http://www.who.int/csr/disease/lassafever/early-diagnostic-lassa-fever/en/. Accessed 19 January 2017.